Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy
- PMID: 8281671
- DOI: 10.1161/01.cir.89.1.361
Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy
Abstract
Background: The early establishment of infarct artery reperfusion by intravenous thrombolytic therapy has improved survival after acute myocardial infarction. Investigations of reperfusion have focused on the effects of specific thrombolytic agents, anticoagulation, and platelet inhibition. However, little attention has been given to the relation of arterial blood pressure to thrombolysis, a factor that probably affects thrombolytic agent delivery to the obstructing thrombus.
Methods and results: The effect of arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation (IABP) on reperfusion after intravenous thrombolytic therapy was studied in a canine model. A critical left anterior descending coronary artery stenosis was created by an occluder. Acute thrombosis immediately proximal to the occluder was formed by local injection of a blood and thrombin mixture into a segment of the artery that had intimal damage (groups 1 through 3). Continuous coronary blood flow velocity was measured by an epicardial Doppler probe. Group 1 (n = 7) served as control. Group 2 (n = 6) received an intravenous, front-loaded recombinant tissue-type plasminogen activator (rTPA) regimen (1.25 mg/kg total dose, 15% as bolus, 50% in the first 30 minutes, and 35% for the following 60 minutes). Group 3 (n = 6) received the same rTPA regimen with IABP beginning at the start of rTPA administration. Coronary blood flow velocity, arterial pressure, and heart rate were observed for 150 minutes after the start of thrombolytic therapy. Five animals did not undergo coronary thrombosis (group 4) and had coronary blood flow velocity determined before and after IABP at baseline and after creation of critical stenosis. Mean systolic arterial blood pressure and heart rate were not statistically different between groups. Peak augmented diastolic pressure by IABP was 97.9 +/- 1.3% of systolic pressure in group 3 dogs. Spontaneous reperfusion did not occur in any group 1 dogs. All animals treated with rTPA reperfused. Reperfusion occurred in group 3 (13.1 +/- 2.1 minutes) earlier than in group 2 (39.2 +/- 9.4 minutes, P = .02). Overall duration of arterial patency did not differ between group 2 (81.4 +/- 16.6 minutes) and group 3 (94.9 +/- 15.3 minutes, P = .52). Reocclusions occurred with similar frequency (P = .85) in groups 2 and 3. In group 4, IABP did not increase baseline coronary blood flow velocity.
Conclusions: This study demonstrates that augmentation of diastolic arterial pressure by IABP enhances thrombolysis, leading to faster reperfusion. This effect appears to be unrelated to an increase in coronary blood flow and may be due to an effect of the augmented diastolic blood pressure wave on the obstructing thrombus. These findings suggest that the time to reperfusion by rTPA may be blood pressure dependent. The relation of arterial blood pressure to successful thrombolysis may have important implications for future treatment strategies for myocardial infarction.
Similar articles
-
Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.Coron Artery Dis. 1994 Nov;5(11):929-36. Coron Artery Dis. 1994. PMID: 7719525
-
Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent.J Am Coll Cardiol. 1994 Mar 1;23(3):794-8. doi: 10.1016/0735-1097(94)90770-6. J Am Coll Cardiol. 1994. PMID: 8113566
-
Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.Cardiovasc Res. 1993 Jun;27(6):925-34. doi: 10.1093/cvr/27.6.925. Cardiovasc Res. 1993. PMID: 8221780
-
Thrombolytic retreatment with tissue plasminogen activator for threatened reinfarction and thrombotic coronary reocclusion.Clin Cardiol. 1994 Jan;17(1):3-13. doi: 10.1002/clc.4960170103. Clin Cardiol. 1994. PMID: 8149679 Review.
-
The importance of early patency after acute myocardial infarction.Curr Opin Cardiol. 1995 Jul;10(4):361-6. doi: 10.1097/00001573-199507000-00004. Curr Opin Cardiol. 1995. PMID: 7549077 Review.
Cited by
-
Intra-aortic balloon counterpulsation pump therapy: a critical appraisal of the evidence for patients with acute myocardial infarction.Crit Care. 1998;2(1):3-8. doi: 10.1186/cc117. Crit Care. 1998. PMID: 11094470 Free PMC article. No abstract available.
-
Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial.J Thromb Thrombolysis. 2005 Feb;19(1):33-9. doi: 10.1007/s11239-005-0938-0. J Thromb Thrombolysis. 2005. PMID: 15976965 Clinical Trial.
-
[Reperfusion therapy and mechanical circulatory support in patients in cardiogenic shock].Herz. 1999 Oct;24(6):448-64. doi: 10.1007/BF03044431. Herz. 1999. PMID: 10546149 Review. German.
-
Thrombolysis in Acute Myocardial Infarction Complicated by Cardiogenic Shock.J Thromb Thrombolysis. 1995;2(1):11-20. doi: 10.1007/BF01063156. J Thromb Thrombolysis. 1995. PMID: 10639210
-
Is Intra-Aortic Balloon Pump Counterpulsation Sufficient to Treat Patients in Cardiogenic Shock, Undergoing Primary Percutaneous Coronary Intervention.Cardiol Res. 2015 Dec;6(6):339-345. doi: 10.14740/cr415w. Epub 2015 Dec 16. Cardiol Res. 2015. PMID: 28197255 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical